The one-glance read on who they are and how they grow. Each point is verifiable from the receipts above.
Nine stackable, hormone-free supplement formulas targeting the 34 recognized symptoms of perimenopause and menopause, sold DTC at season34.com and on Amazon, with individual formulas priced at $49.99 one-time (about $37.49 on subscription), launched in January 2026 with seven trade-press features in the first 30 days and a NEXTY Award finalist designation at Natural Products Expo West.
Credential-led at launch, with a brief paid-search and video push in the pre-launch window, now running on Instagram organic with no detectable paid acquisition.
Approximately 661 estimated monthly visits; 4,036 Instagram followers across 84 posts; 11 Google ads that ran from November 2025 through early January 2026, all now inactive.
Season34 opened doors fast by leading with a clinical co-founder's OB/GYN credentials and earning seven trade features in its launch month, but six months post-launch it has not yet built a scalable acquisition channel and traffic is declining.
The order the channels came online. Sequence is strategy: what they did first, and what they layered on once demand existed.
Estimated demand, the channel split behind it, and the keywords and referrers doing the work. Directional modeling, not audited analytics.
| Keyword | Volume | Weight | CPC |
|---|---|---|---|
| season 34 menopause | 110 | - | |
| season 34 supplements | 30 | - | |
| season34 | 30 | - | |
| it blends beauty with perfomance | 10 | - | |
| it blends beauty with performance | 10 | - |
Estimated monthly visits are approximately 661, with a 16.3% decline over the prior three months as of June 30, 2026. The platform does not break out the marketing channel mix at this traffic level, but the keyword evidence fills the gap: every keyword Season34 ranks or bids for is branded ("season 34 menopause," "season34," "season 34 supplements"), meaning virtually all visits arrive from people who already know the brand name, not from unbranded discovery searches. The one blog post on the site earns approximately 0 organic visits per month, accounting for the entirety of their organic search footprint. No referral sources or active paid traffic are detectable. The declining trend against an already small base signals that the January 2026 earned-media launch wave has fully decayed and no channel has yet replaced it as a source of new visitors.
Free-to-paid conversion rate, CAC, and churn are not visible in public data. Revenue is not publicly disclosed; given approximately 661 monthly visits, a typical DTC supplement conversion rate, and products priced at $49.99 one-time (about $37.49 on subscription) per formula, the DTC site likely generates a few hundred dollars per month at most. Amazon sales contribution is not visible in public data. These are order-of-magnitude estimates only.
The specific pages earning their organic search traffic, and the pattern behind why they rank. Adapt the format, not the topic.
Their sole ranking page, "The 34 Symptoms of Menopause: The Signs No One Warns You About," earns approximately 0 organic visits per month and ranks #22 for the Tagalog-language query "34 sintomas ng menopause" rather than any English or Spanish search term. The format is a comprehensive numbered symptom explainer, the correct archetype for this category: long-form, medically specific, organized by symptom cluster. The current ranking is incidental (a low-competition Tagalog query rather than the English or Spanish terms the brand is likely targeting), but the underlying format, a named, numbered, clinically detailed problem list, is the right SEO building block for women's health authority. Expanding this approach intentionally in English and Spanish, against the demand the brand's bilingual YouTube library suggests it is pursuing, is the obvious next layer.
Not traffic share. How much weight the growth system actually puts on each channel, with a one-line read on the role it plays.
Each exhibit shows the actual asset, an X-ray of why it works, a status, and a play you can adapt. This is the heart of the teardown.
The Google Ads library shows 11 total ads, all inactive as of June 30, 2026. The full campaign ran from November 2025 through early January 2026, a pre-launch buildup and launch-month push that has since paused entirely. No active Meta ads are detectable beyond the library link. There is no running paid acquisition on any platform visible in public data.
Three creative angles from the launch campaign illustrate the positioning strategy:

Why it works. Reframes a supplement ad as a sleep-science explainer, matching the intent of perimenopausal women researching insomnia rather than shopping a brand.
Headline and sub-headline: 'Stages of restful sleep' and 'With sleep & relaxation by SEASON34'. Pair your product shot with an educational diagram tied to the outcome you promise, so the ad reads as information first and a pitch second.

Why it works. Opens with the skepticism perimenopausal buyers already feel about supplement claims, then answers it with a natural-ingredient product shot to rebuild trust.
Direct question and bold claim at the top: "Do your menopause supplements actually work?" followed by "This one does". Open with the exact doubt your buyer already has about your category, then answer it plainly with your product as the proof.
No third-party creator posts, affiliate sellers, or community amplification is visible in public data. Season34 received coverage from trade publications including Personal Care Insights, Fitt Insider, BeautyMatter, Nutrition Insight, Trend Hunter, Nutraceuticals World, NutraIngredients, and Drug Store News in January 2026, but this was driven by the launch event and NEXTY nomination, not an ongoing amplifier network. No named creators, Reddit threads about the brand, or UGC surfaces in the evidence. Co-founder and CEO Irene Rojas Stanbury (who founded Season34 with her mother, veteran gynecologist Dr. Maria Stanbury, the clinical credential behind the brand) is listed as the Google Ads account holder; no separate founder-led social or build-in-public presence is visible in the scraped data.
The organic content engine: the videos, creator posts, and community presence earning attention without paid spend.
Instagram is Season34's only consistently active owned channel. The brand posts at roughly 3 to 4 times per week, and the content mix, based on visible posts, runs three angles: clinical statistics that dramatize a specific menopause symptom (e.g., the insulin resistance and sleep finding), community mirroring (resharing anonymized voices from r/Perimenopause to signal "we see you"), and product education tied to a specific formula's mechanism. At 119 average engagements per post against a 4,036-follower base, the content is retaining attention at the top of the funnel. Whether the Instagram audience is converting to purchasers is not visible in public data.
The YouTube library is a batch-produced content infrastructure: 21 videos, each covering one formula or symptom cluster, uploaded in English and Spanish on the same day before the DTC launch. Each follows a consistent structure: explain the symptom mechanism clinically, connect it to the formula. The library's function at this stage appears to be paid-video creative inventory rather than organic search discovery, given the near-zero organic view counts on most videos.
How the brand turns creators and partners into a tracked, variable-cost acquisition channel, and how the program is structured.
No affiliate program is detected on the Season34 site, and no TikTok Shop seller activity or referral tracking parameters appear in the evidence. At this stage of traffic and community size, the absence of a formal affiliate program is expected rather than a strategic gap: the audience density and brand awareness required to recruit and train an affiliate pipeline are not yet in place.
The channels are not separate. They are one system where each stage feeds the next. Here is the read, then the plays to run tomorrow.
Season34 launched on clinical credibility and earned media, then paused all paid acquisition, leaving Instagram as the only live growth engine at a stage where the brand has yet to discover its repeatable customer-acquisition motion.
Co-founder Dr. Maria Stanbury's 35-plus years as an OB/GYN gave trade journalists a credible clinical expert to quote rather than a typical DTC supplement pitch, producing seven features in the launch month and a NEXTY Award finalist slot six weeks post-launch. This is the strongest card Season34 has played and the foundation its credibility rests on.
Eleven Google ads ran image, video, and text formats from November 2025 through early January 2026, then stopped entirely. Whether this was a deliberate strategic pause after a test period or a budget constraint is not visible in public data. The path from that launch push to the current declining traffic is not explained in public sources.
Eighty-four posts, 4,036 followers, roughly 3% engagement. The brand is maintaining audience contact and demonstrating content discipline, but the channel is not generating the traffic or revenue volume needed to validate the business model at scale.
No creator or affiliate distribution, no unbranded SEO footprint, no active paid acquisition. The brand's founding architecture is differentiated (clinical co-founder, bilingual positioning, nine symptom-specific formulas), but the distribution loop to turn that differentiation into customer flow has not yet been built.
The proofSeason34 earned seven trade-press features in its launch month with a brand fewer than 30 days old. The lever was co-founder Dr. Maria Stanbury's 35-plus years as an OB/GYN, which gave editors a credentialed expert to cite rather than a supplement marketing claim. The NEXTY Award finalist nomination reinforced the same expert-backed signal in a different channel (trade shows).
The adaptationIf your brand has a clinical, academic, or deep-domain-expert co-founder, structure your initial press pitches around that person's credentials as the primary hook, with the product as the application of their expertise. Identify five trade publications in your vertical that cover expert-backed launches rather than product releases and pitch them in the same two-week window to create a coverage cluster. The mechanism: trade editors in regulated categories (health, food, finance, legal) use credentialed experts as a screening shortcut to legitimacy, and simultaneous multi-outlet coverage creates a momentum perception a single feature cannot.
The proof"34 symptoms" is baked into Season34's brand name, their only ranking blog post, their YouTube video titles, and their ad hooks. Every piece of content maps back to a number the audience can recognize as comprehensive and specific, distinguishing the brand from generic "menopause support" competitors.
The adaptationIdentify the specific, countable problem at the center of your product's value proposition: the number of compliance rules you cover, the number of manual steps you eliminate, the number of failure modes you prevent. Build your homepage, content strategy, and ad hooks around that number. First step: audit your top three competitors' homepages for their primary claim. If they use vague category language ("comprehensive," "all-in-one," "complete solution"), a precise number creates instant differentiation and gives journalists and affiliates a concrete data point to quote.
The proofSeason34 uploaded 21 educational videos on a single day, December 30, 2025, in English and Spanish simultaneously, one video per formula or symptom cluster, before the DTC launch date. The brand's Florida base and Spanish-language content depth suggest Latinas 35-plus are a core segment.
The adaptationIf your total addressable market includes a significant bilingual demographic (Spanish, Portuguese, French, Tagalog), produce the full content library in both languages before you launch distribution. Don't sequence it as "English first, then localize later." Producing both languages together in a single production sprint is faster (same script, adapted rather than translated), and prevents the common pattern of the non-English version never getting made once the team is stretched. First step: estimate what percentage of your addressable market is bilingual and whether English-language content in your category already saturates that segment. If 20-plus percent of the market is underserved in their preferred language, include both languages in the production budget from day one.
The proofSeason34 was named a NEXTY Award finalist at Natural Products Expo West approximately six weeks after its DTC launch. The nomination (not a win) became a credibility signal running alongside the January 2026 trade press wave, giving editors a third-party imprimatur to cite in coverage of a brand with no sales history.
The adaptationResearch the flagship awards program in your product's trade category and submit before you have revenue or meaningful traction. Most industry awards accept applications from early-stage companies, and a "finalist" designation is a credibility statement that no press release can manufacture. Pair the nomination announcement with your press outreach so both land in the same news cycle. The mechanism: trade editors and retail buyers treat award nominations as a vetting signal (someone credible evaluated this product), which lowers their bar to coverage. Note that this play works best in categories with established trade shows and formalized award programs; not every vertical has an equivalent.
The proofSeason34 offers nine formulas, each addressing a named cluster of the 34 recognized menopause symptoms (sleep, hormonal balance, metabolic, urinary, mood, beauty, bone and joint, and others). Each formula has its own ad hook, its own educational video, and its own reason to purchase. A customer who enters for sleep support has a natural reason to add the hormonal balance formula later. The product architecture creates a multi-SKU purchase journey where a single-product brand has only one shot.
The adaptationIf your product category involves multiple distinct pain points that different customers prioritize differently, build or position your product line so each SKU maps to one distinct problem cluster rather than bundling everything into one omnibus product. This gives you a different acquisition entry point per customer type and a natural cross-sell sequence once trust is established. First step: survey your existing customers on their top three pain points from your category. If two or three clearly distinct clusters emerge, consider whether a named sub-product per cluster (each with its own hook and landing page) outperforms one generic product pitched to all of them.
Every morning we take one company that is actually growing and break down where its customers come from: the ads still running after a year, the channel doing the real work, and the play you can run this week.
Systemaic · directional intelligence. Traffic, spend, and reach figures are SimilarWeb-style estimates and qualitative reads of public data, not audited numbers. Built on real public receipts.
Live ad libraries: google ad library
Traffic, spend, and revenue figures are estimates as noted in the report; the links above are the primary public artifacts.